SCHEMBL2804861

SCHEMBL2804861

c1ccc(C2Cc3cnc(NC4CCC4)nc3-c3ccccc32)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.61
FGFR2 P21802 2/20 0.61
ADORA1 P30542 4/20 0.47
MAPT P10636 1/20 0.44
CCNA2 P20248 4/20 0.39
CDK2 P24941 4/20 0.39
CCNA1 P78396 4/20 0.39
AURKA O14965 1/20 0.39
CDK7 P50613 2/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
CSF1R P07333 1/20 0.38
FGFR3 P22607 1/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.36
ULK1 O75385 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806784 0.97 FGFR1 (0.60) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2805457 0.97 FGFR1 (0.60) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2804795 0.91 FGFR1 (0.51) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2802427 0.91 FGFR1 (0.51) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2803454 0.88 FGFR1 (0.50) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2804944 0.88 FGFR1 (0.50) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2808072 0.88 ADORA1 (0.50) FGFR1FGFR2ADORA1CCNA2CDK2
SCHEMBL2804983 0.86 ADORA1 (0.47) FGFR1FGFR2ADORA1CDK2CDK7
SCHEMBL2804221 0.86 FGFR1 (0.51) FGFR1FGFR2ADORA1MAPTCCNA2
SCHEMBL2802238 0.85 FGFR1 (0.53) FGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885ADORA1 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.